We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GSK CITIZEN PETITION SEEKS TO BLOCK GENERIC FLONASE
GSK CITIZEN PETITION SEEKS TO BLOCK GENERIC FLONASE
June 15, 2004
GlaxoSmithKline (GSK) has filed a citizen petition asking the FDA to delay approving generic versions of its allergy nasal spray Flonase (fluticasone propionate) until the agency issues final guidance on establishing equivalency for inhalers.